FDA Relents from Midodrine Withdrawal Plan Published: Sep 07, 2010 AP -- NEW YORK — Federal regulators have backed off a plan to remove a Shire PLC low blood-pressure treatment from the market after warning in August that the drug has not been proven effective. Related links NPR News This will open in a new window AP This will open in a new window Kansas City Business Journal This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news